Pharmaceutical pricing is a focus of numerous governments throughout the world. Methods can include regulating distribution changes, reference pricing (either internal or external), promotion of generics, and tariff or tax exemptions.1 The goal of all these varying methods is to achieve cost containment – i.e., reduction in spending for pharmaceuticals or capping the possibility of increasing costs.
Another common area of focus for governments is encouraging investment within the domestic market. We have seen this play out in the…
